Analyst Ratings for Idera Pharmaceuticals (IDRA) [Neutrals]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/19/2021 | Wedbush | Robert Driscoll | Downgrade | Neutral (Outperform) |
N/A (N/A) |
5.21 (0.43) |
-91.75% | Details |
3/19/2021 | Barclays | Gena Wang | Downgrade | Equalweight (Overweight) |
2.00 (N/A) |
5.13 (0.43) |
-91.62% | Details |